GPT and metabolic dysfunction-associated steatotic liver disease: Monitoring of markers of liver function, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and albumin, and markers of lipid metabolism such as triglycerides (TG), cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), as well as abdominal ultrasound, are the most commonly used methods for assessing various diseases including NAFLD risk [11,12,13,14].